ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HGEN Hydrogenone Capital Growth Plc

24.15
0.00 (0.00%)
Last Updated: 15:00:33
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hydrogenone Capital Growth Plc LSE:HGEN London Ordinary Share GB00BL6K7L04 ORD GBP0.01
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.00% 24.15 144,330 15:00:33
Bid Price Offer Price High Price Low Price Open Price
25.00 26.40
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Trust,ex Ed,religious,charty 9.36M 7.32M 0.0568 4.25 31.11M
Last Trade Time Trade Type Trade Size Trade Price Currency
15:13:09 O 4,815 25.2191 GBX

Hydrogenone Capital Growth (HGEN) Latest News

Hydrogenone Capital Growth (HGEN) Discussions and Chat

Hydrogenone Capital Growth Forums and Chat

Date Time Title Posts
20/11/202409:46HYDROGENONE CAPITAL IPO351

Add a New Thread

Hydrogenone Capital Growth (HGEN) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
15:13:1025.224,8151,214.30O
15:00:3525.131,124282.46O
14:43:2626.4030.79O
14:43:2624.6051.23O
14:42:0324.9926,2806,566.93O

Hydrogenone Capital Growth (HGEN) Top Chat Posts

Top Posts
Posted at 21/11/2024 08:20 by Hydrogenone Capital Growth Daily Update
Hydrogenone Capital Growth Plc is listed in the Trust,ex Ed,religious,charty sector of the London Stock Exchange with ticker HGEN. The last closing price for Hydrogenone Capital Growth was 24.15p.
Hydrogenone Capital Growth currently has 128,819,999 shares in issue. The market capitalisation of Hydrogenone Capital Growth is £31,110,030.
Hydrogenone Capital Growth has a price to earnings ratio (PE ratio) of 4.25.
This morning HGEN shares opened at -
Posted at 14/11/2024 19:07 by pj84
Yes, monetising one of the other investments is key to restoring shareholder value.

Understandably the managing partners are always optimistic on the prospects and the following must be taken with a pinch of salt, but in the Q & A last week Richard Hulf, when asked whether after the Gen 2 sale, that was it for 24, replied, “this is it for now, but we haven’t finished 24 yet.” And JJ Traynor when asked, have you any other asset sales planned? Answered “yes, that’s our business model.”

I am always wary of catching a falling knife but will be tempted to top up when it looks like it has finally reached the bottom, as the current price is virtually pricing insolvency for the majority of the holdings.
Posted at 14/11/2024 09:46 by pj84
For now at least HGEN's working assumption is the NAV is now about 92p and they are not expecting to recover anything from HH2E.
Posted at 10/11/2024 16:15 by craigso
It certainly does make sense that there could be a floor to the share price somewhere around here, based on the handful of assets that look particularly solid.

But as a DGI9 investor, I can attest that once the market stops believing NAVs - especially those that require follow-on investments to unlock - there's very little to be done except to hang on and hope for real, cash realisations - something I wouldn't expect in the hydrogen space. Unfortunately the optics are terrible here...
Posted at 08/11/2024 14:44 by pj84
As a current holder saying I am disappointed so soon after the recent update emphasising the foundation of the NAV following the Gen2 sale is an understatement.

The shares were already on a 60% discount so a lot of bad news already in the price.

As the 8% holding in HH2E was already discounted to just 3.2p of the previous market cap the fall today of nearly 10p does appear to be harsh.

It is hardly surprising for those who decide to sell that there will be less demand by buyers to buy today and inevitably that means the price will fall to the amount the few buyers are willing to pay.

It also means a bigger discount is now being applied to the remaining portfolio holdings of closer to 70%.

I have decided to remain patient and to continue to hold, on the basis that the administration of one of the smaller holdings doesn't mean all holdings are destined for the same fate.

The NAV of Sunfire of approx 25p almost makes up the current share price of 28p on it's own and it wouldn't take a lot of growth for that to justify the share price on it's own.

Sunfire is one of the world's largest manufacturer's of electrolysers and this was from the RNS earlier this year regarding it's most recent fundraising: -

"The Company's Investment Adviser, HydrogenOne Capital LLP, believes this is a significant financial milestone for Sunfire, with EUR 215 million raised in a Series E equity financing round, further complemented by a term loan of up to EUR 100 million provided by the European Investment Bank ('EIB'). In addition, Sunfire has access to circa EUR 200 million from previously approved, undrawn grant funding to support its growth. The transaction is subject to customary regulatory approvals and is expected to close in Q2 2024. This makes Sunfire one of the best capitalised electrolyzer manufacturers in the industry.

Sunfire is an industry leader in alkaline and solid oxide electrolyser manufacture. Sunfire is expanding its alkaline electrolysis production capacity at Solingen and Limbach-Oberfrohna, Germany and developing advanced research facilities in Dresden. Sunfire's pressurised alkaline and high-temperature solid oxide electrolysis technologies have the potential to become key enablers of the transition to renewable energy, offering a scalable and efficient means of producing green hydrogen. Accordingly, Sunfire targets installing several gigawatts of electrolysis equipment by 2030 in large-scale green hydrogen projects, securing a leading position in the fast-growing global electrolyzer market."
Posted at 08/11/2024 13:13 by 31337 c0d3r
To be fair, Foresight only pulled their funding yesterday, and HGEN reported it first thing this morning.
Posted at 08/11/2024 13:07 by kooba
Maximum 8% off assets leads to 25% off an already highly discounted share price looks harsh , but unfortunately it not only impacts on this holding it's now about the lack of trust in the valuation models ...those discounting future revenues without the funding in place are rather flakey as can been seen.Other holdings are further down the line or supported by recent fundraises one hopes will hold up but it appears Foresight has the foresight that using available cash to buy back shares at a huge discount is a better use of funds than committing more to investments that the market value so poorly it seems.
Posted at 08/11/2024 11:00 by brinton62
Have a look at FGEN. They where also involved in the funding and decided not to go ahead. Doens quite read likenthat in the HGEN RNS!
Posted at 08/11/2024 09:14 by craigso
Very happy to have sniffed around this and passed.

Publishing a NAV including £11m for HH2E and having that go to zero two days later shows that management are either totally incompetent or are lying about valuations.

The floor on the share price is much lower than this...
Posted at 11/9/2024 13:56 by cc2014
The stock market is a funny thing but the share price appears to be indicating HGEN has either massively overpaid or there is little future in Hydrogen as an energy storage medium.

I'm not getting it really. Hydrogen is a bit of a tricky molecule as it's so small.
Posted at 07/8/2023 17:28 by pj84
Hoping to catch up with today's investormeet presentation later but just quickly read the following update



HydrogenOne jumps 12% after second-quarter uplift to valuations

HydrogenOne Capital Growth narrows its wide discount after eking out a small rise in NAV as gains in its unquoted portfolio offset the impact of rising interest rates.

BY JAMIE COLVIN

Shares in HydrogenOne Capital Growth (HGEN) jumped 12% to 55p today as the investment trust continued this year’s volatile run after impressing sceptical investors with a small second-quarter rise in net asset value (NAV) accompanied by a surge in revenues from its 10 loss-making companies.

Speaking to shareholders, co-manager Richard Hulf said there was a complete disconnect between the NAV, which rose 0.7% to 100.7p in the three months to 30 June, and the shares, which closed at a yawning 51% discount on Friday, which is among the widest valuation gaps in the renewable infrastructure sector.

Launched two years ago, HydrogenOne shares peaked at 120p in November 2021 before more than halving to their current level as investors questioned the valuation of its unquoted assets as inflation and interest rates rose rapidly.

Nevertheless, the latest update showed good valuation uplifts to its private equity positions in green hydrogen companies in the UK and Europe, even though an increase in its discount valuation rate from 12.8% to 13.7% weighed on the NAV and offset most of the gains.

Total revenues of £52m over 12 months marked a 170% increase year on year leaving the closed-end fund with cash of £8.9m and £3m in listed hydrogen companies that could be sold if necessary after making £2.6m of follow-on investments in Cranfield Aerospace Solutions and Thierbach (a development project for the construction of an industrial scale green hydrogen producer in Germany).

Despite earlier reassurances to investors that there was nothing amiss with the portfolio, HGEN shares have tumbled 38% this year. Hulf blamed macroeconomics for depressing sentiment rather than trust-specific news.

‘Company revenues are growing, businesses are doing well, new projects are starting up and governments are increasingly putting money in,’ said Hulf (pictured below left, with co-manager JJ Traynor). ‘Hydrogen has had many false starts, but is now going ahead. We’ll show that through the interim results next month.’

Richard Hulf and JJ Traynor - HydrogenOne
He implied that the trust conservatively values its assets, with last month’s flotation of the green hydrogen firm Thyssenkrupp Nucera, which has been valued at €3bn, having a direct read across with HGEN’s largest holding, Sunfire, a leading German industrial electrolyser producer in which the fund has 20% invested.

In terms of the trust’s pipeline, Hulf said they were looking into US green hydrogen projects that benefited from the Inflation Reduction Act. However, investments there would have to wait until the trust regained a premium over NAV in order to raise more capital through a share issue.

Hulf emphasised that as a growth fund, they did not have the cash available to buy back stock, but would ‘think about it’ with the proceeds of any exits. He added that that could be as soon as next year when some of their investments would meet the minimum threshold of two times return on invested capital.

Liberum analyst Joe Pepper said valuing private market hydrogen companies was difficult given the nascent, loss-making nature of the portfolio, but continued to view the share price as overly discounting the challenges. He added that HGEN’s share price was highly volatile and underperforming listed hydrogen peers in the US.
Hydrogenone Capital Growth share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock